Company Filing History:
Years Active: 2005-2010
Title: Lumir Hanus: Innovator in Cannabinoid Research
Introduction
Lumir Hanus is a prominent inventor based in Jerusalem, Israel, known for his significant contributions to the field of cannabinoid research. With a total of four patents to his name, Hanus has focused on developing pharmaceutical compositions that utilize cannabidiol derivatives for various therapeutic applications.
Latest Patents
Hanus's latest patents include innovative pharmaceutical compositions comprising cannabidiol derivatives. These compositions are designed to serve as anti-inflammatory agents with analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic, and anticancer properties. The invention also details a process for preparing these cannabidiol derivatives and their use in medicaments for treating human ailments. Another notable patent involves agonists specific for the peripheral cannabinoid receptor. This invention presents novel pharmaceutical compositions that include 4-phenyl pinene derivatives, which specifically bind to CB2 receptors without affecting CB1. These compounds have shown potential in managing hypertension, inflammation, pain, gastrointestinal diseases, autoimmune diseases, and tumors.
Career Highlights
Hanus is affiliated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where he continues to advance his research in cannabinoid applications. His work has garnered attention for its potential to revolutionize treatments for various medical conditions.
Collaborations
Throughout his career, Hanus has collaborated with esteemed colleagues such as Ester
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.